Gastroenterology | Mapi Research Trust

Lead text placeholder. Lorem ipsum dolor sit amet, consectetur adipisicing elit.

Articles

2017. Pavel ME et al. – Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2017. Igarashi A et al. – Cost-utility analysis of sofosbuvir for the treatment of genotype 2 chronic hepatitis C in Japan
2017. Igarashi A et al. – Cost-utility analysis of ledipasvir/ sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan
2016. Zech J et al. – Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial
2016. Cassuto et al. – Adherence to and acceptance of once-daily tacrolimus after kidney and liver transplant: Results from OSIRIS, a French observational study
2016. Bianic F et al. – Cost-effectiveness of everolimus plus reduced tacrolimus in de novo liver-recipients in the Italian setting
2015. Cure S et al. – Cost-effectiveness of sofosbuvir for the treatment of chronic hepatitis C-infected patients
2015. Cure S et al. – Cost-effectiveness of sofosbuvir plus ribavirin with or without pegylated interferon for the treatment of chronic hepatitis C in Italy
2015. Chassany O et al. – The Intestinal Gas Questionnaire: Development of a new instrument for measuring gas-related symptoms and their impact on daily life
2014. Gilet H et al. – Measuring patients’ satisfaction with their anti-TNF treatment in severe Crohn’s disease: Scoring and psychometric validation of the satisfaction for patients in Crohn’s disease questionnaire (SPACE-Q)
2011. Marant C et al. – Assessing patients’ satisfaction with anti-TNFalpha treatment in Crohn’s disease: Qualitative steps of the development of a new questionnaire
2010. Dubois D et al. – Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation

Posters & Presentations

2017. Congrès du G.F.H.G.N.P – Pleurs et inconfort du nourrisson (ColIQ©): Développement d’une échelle d’évaluation standardisée
2016. Journées d’Automne de Pédiatrie et Néonatologie – Prise en charge des pleurs et inconfort digestif du nourrisson: Evaluation standardisée en consultation pour les parents
2016. BSG Conference – Indicators of Suboptimal Therapy Among Crohn’s Disease Patients Treated with Tumor Necrosis Factor Antagonists: Results from a Multi-National Study
2016. BSG Conference – A Multinational Study to Determine Indicators of Suboptimal Therapy Among Ulcerative Colitis Patients Treated with Tumor Necrosis Factor Antagonists
2016. ASCO Annual Meeting – Association of Disease Progression, Health-Related Quality of Life, and Utility in Patients with Advanced, Nonfunctional, Well-Differentiated Gastrointestinal or Lung Neuroendocrine Tumors in the Phase 3 Radiant-4 Trial
2015. ISPOR European Congress – Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients with Chronic HCV in the Netherlands
2015. ISPOR European Congress – Cost-Effectiveness of Cetuximab in First-Line Treatment of Patients with Metastatic Colorectal Cancer in Belgium and the Netherlands
2015. ISPOR European Congress – Consequences of Biomarker Analysis on the Cost-Effectiveness of Cetuximab in Combination with Irinotecan Based Chemotherapy for First-Line Treatment of Metastatic Colorectal Cancer. Stratifed Medicine at Work?
2015. ISOQOL Annual Conference – Health-Related Quality of Life in CLARINET, a phase III Trial of Lanreotide Autogel 120 mg in Patients with Non-Functioning Entero-Pancreatic neuroendocrine Tumour: Analytical Challenges and Statistical Solutions
2015. ISPOR Annual International Meeting – Importance of the Conceptual Definition of PRO Measures: A Case Study with the Linguistic Validation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) Instrument in 17 Asiatic Languages.
2014. ISPOR European Congress – A Systematic Literature Review to Identify Trials in First-line RAS Wild-Type (WT) Metastatic Colorectal Cancer (MCRC) Patients
2014. ISPOR European Congress – Accept® Questionnaire: Relation between Acceptance and Compliance in Liver- and Kidney-Transplanted Patients Converted to Once-Daily Tacrolimus
2014. ICPE Meeting – Real World Utilization and Management of Adverse Events in Patients Treated with Direct Acting Antivirals (DAAs) in a European Cohort of Chronic Hepatitis C (CHC) Patients
2013. ISPOR European Congress – What Value Can Operational Feasibility Studies Bring to Post Marketing Observational Studies (PMOS)? Example of Feasibility Study Performed in Eastern Europe to Assess Hepatitis C Viral Disease/Patient Management in Real World Setting
2013. ISPOR European Congress – Systematic Literature Review in Moderate to Severe Ulcerative Colitis
2013. ISPOR European Congress – Network Meta-Analysis of Approved Biologic Interventions for the Induction of Response in Ulcerative Colitis
2013. ISPOR European Congress – Network Meta-Analysis of Approved Biologic Interventions for the Maintenance of Response in Ulcerative Colitis
2012. ISPOR European Congress – Characteristics of Long-Acting Somatostatin (SSA) Use in Gastro-Entero-Pancreatic Neuroendocrine (GEP-NET) Tumors in the Netherlands
2012. ISPOR European Congress – Cost-Effectiveness Analysis of Immunonutrition for Upper Gastrointestinal Cancer Patients Undergoing Surgery in British Hospitals
2012. ISPOR European Congress – Assessing Gas-Related Symptoms and their Associated Impact on the Daily Life of the General Population and Irritable Bowel Syndrome Patients: International Development of a Questionnaire – Qualitative Steps
2012. ISPOR European Congress – Finalisation and Psychometric Validation of a New Questionnaire Measuring Patient Satisfaction with Anti-TNF Treatments in Severe Crohn’s Disease
2012. ACG Annual Meeting – Randomized controlled trials of treatments for irritable bowel syndrome with constipation and chronic constipation: Evaluation of measurement and reporting of efficacy and identification of evidence gaps
2012. ISPOR Annual International Meeting – The Cost- Effectiveness of Telaprevir (TVR) in Combination with Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1 (G1) Chronic Hepatitis C Patients: A Post-Hoc Analysis of IL-28B Subgroup
2012. ISPOR Annual International Meeting – The Cost-Effectiveness of Telaprevir (TVR) in Combination with Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Geneotype 1 (G1) Chronic Hepatitis C Patients.
2011. ISOQOL Annual Conference – The Impact of Irritable Bowel Syndrome with Constipation (IBS-C) on Children and Adolescents: Results from Qualitative Research
2011. ISOQOL Annual Conference – The Impact of Chronic Constipation (CC) on Children and Adolescents: Results from Qualitative Research
2011. ISPOR Annual International Meeting – IBS-C Patient Symptom Reports: Analysis of Exploratory Open-Ended Questions
2010. ISPOR European Congress – Child and Parent Reports of Symptoms of Irritable Bowel Syndrome with Constipation (IBS-C): Results of Qualitative Interviews
2010. ISOQOL Annual Conference – Psychometric Validation of the Ascites Impact Measure Questionnaire to Assess Patient Symptoms that Trigger a Paracentesis
2010. ISOQOL Annual Conference – The Development of the Ascites Impact Measure questionnaire to Assess Patient Symptoms that Trigger a Paracentesis
2010. ISOQOL Annual Conference – Conceptual Definition of PRO Measures: A Case Study with the Quality of Life in Inflammatory Bowel Disease Questionnaire (IBDQ)
2010. ISOQOL Annual Conference – Development of a Pediatric Chronic Constipation Symptom Measures: Results of Qualitative Interviews with Children and Their Parents
2010. ISOQOL Annual Conference – Development of Symptom Measures Reflecting the Relative Impact of Symptoms on Health-Related Quality of Life: Application to Chronic Constipation. In SYMPOSIUM 1538: The Challenges of Symptom Assessment in Clinical Research: Illustrations in Gastrointestinal Conditions
2010. ISOQOL Annual Conference – Similarities and Differences in the Expression of Symptoms Across Countries: The Translations of the PAGI-SYM 20. In SYMPOSIUM 1538: The Challenges of Symptom Assessment in Clinical Research: Illustrations in Gastrointestinal Conditions
2010. ISOQOL Annual Conference – The Symptoms of Irritable Bowel Syndrome with Constipation (IBS-C): Results of Qualitative Interviews with Children and their Parents. In SYMPOSIUM 1538: The Challenges of Symptom Assessment in Clinical Research: Illustrations in Gastrointestinal Conditions.
2009. ISPOR European Congress – Development of a Questionnaire to Evaluate Treatment Satisfaction of Patients with Severe Crohn’s Disease: Qualitative Steps
2008. ISPOR Annual International Meeting – Linguistic Validation of the Inflammatory Bowel Disease Questionnaire (IBDQ) in 35 languages
1999. ISPOR Annual International Meeting – Quality of Life in Crohn Disease: A Prospective Longitudinal Study in 231 Patients